Cite

HARVARD Citation

    Ballard, P. et al. (n.d.). Metabolic disposition of AZD8931, an oral equipotent inhibitor of EGFR, HER2 and HER3 signalling, in rat, dog and man. Xenobiotica. pp. 1083-1098. [Online]. 
  
Back to record